Delivery Order SPE2DE22D0008-SPE2D624F0BBJ

Award Date 8/20/24
Potential Completion Date 8/23/24
Potential Value $7.9K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chicago, IL 60607, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to various federal agencies. The contract, valued at $2,370.00, is for the delivery of ALBACLONE anti-B products. The award is not associated with a set-aside program and is a Firm Fixed Price Delivery Order contract type. Alba...
This contract, awarded by the Defense Logistics Agency (DLA), is a Delivery Order for $14,457.00 with Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to various U.S. government agencies. The contract is for the delivery of ALBACLONE Anti-A products and has a completion date of September 5, 2024. This contract is not designated as a set-aside. Alba...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, and quality control materials to various U.S. government agencies. The contract, valued at $22,621.60, is a delivery order for "ALBACLONE ANTI-D BLEND" products. It is a firm fixed-price contract with a period of performance ending on...
This federal contract award to Alba Bioscience, Inc., a foreign-owned for-profit organization, is for the supply of specialized in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials. The contract, valued at $6,750.00, was awarded by the Defense Logistics Agency (DLA) Medical Supply Chain division to support defense medical operations. The contract is a delivery order under a larger Indefinite Delivery Vehicle (IDV), likely a Blanket Purchase Agreement...
This is a federal contract award to Alba Bioscience, Inc., a for-profit organization specializing in in vitro diagnostics and blood banking supplies. The contract, with a ceiling value of $12,975.00, is a delivery order awarded by the Defense Logistics Agency (DLA) for the supply of ALBACLONE Anti-C (Big C) medical products. The contract is a firm fixed-price delivery order with an ultimate completion date of April 15, 2025. The contract is not set aside for any specific type of business. Alba...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $2,832.45 to Alba Bioscience, Inc., a foreign-owned, for-profit organization specializing in in vitro diagnostics and blood banking products. The contract, identified as SPE2DE22D0008|SPE2D625F17Y7, is for the delivery of ALBACLONE anti-FYB medical supplies by December 2, 2024. This award is not designated as a set-aside contract. Alba Bioscience is a subsidiary of...
This federal contract award, with ID SPE2DE22D0008|SPE2D625F1414, was issued by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in in vitro diagnostics, blood bank reagents, and quality control materials. The contract, with a ceiling value of $1,118.00, is for the delivery of "ALBACLONE ANTI-A" products, which are likely blood typing reagents or antibodies used in blood banking operations. The contract is a Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned for-profit organization that specializes in in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials. The contract, valued at $1,001.00, is a delivery order for the procurement of ALBACLONE Anti-E (Little E) products. Alba Bioscience has secured numerous federal contracts with agencies such as the Department of Veterans Affairs (VA) and...
This federal contract award, with the ID SPE2DE22D0008|SPE2D624F7DW1, was issued by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials. The $1,906.00 firm-fixed-price contract is for the delivery of ALBACYTE antibody screening (3-cell) products, with a period of performance ending on October 8, 2024. Alba Bioscience is a...
This federal contract award SPE2DE22D0008|SPE2D625F22W7 was issued by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned, for-profit organization specializing in in vitro diagnostics, blood bank reagents, and quality control materials. The $5,160.00 firm fixed-price delivery order contract is for the provision of ALBACYTE antibody identification panels, a critical product supporting blood banking operations across federal healthcare systems. Alba Bioscience, a...
  • SPE2DE22D0008
    Indefinite Delivery Contract
  • SPE2DE22D0008-SPE2D624F0BBJ
    Delivery Order

This federal contract award, valued at $7,900.00, was issued by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, and quality control materials to various U.S. government agencies. The award, classified as a Delivery Order under a Firm Fixed Price contract, is for the supply of ALBACLONE Anti-C (Big C) products. The contract has no set-aside designation and has an ultimate completion date of August 23, 2024.

Alba Bioscience is a subsidiary of Quotient Biodiagnostics, Inc. and is a leading supplier of specialized biomedical products and services, primarily supporting blood banking operations across federal agencies such as the Department of Veterans Affairs (VA), DLA, and Department of Health and Human Services (HHS). The company has secured numerous contracts with the DLA Troop Support Medical division, as well as multiple Blanket Purchase Agreements (BPAs) with the VA, allowing for the streamlined procurement of critical blood banking supplies.

Generated 11/19/24, 9:19 AM